Search for a command to run...
Nureca Ltd. is facing significant financial challenges compared to its peers in the Medical Equipment/Supplies/Accessories sector. With negative earnings, low profitability metrics, and overvaluation, it appears to be underperforming. Meanwhile, Poly Medicure Ltd. stands out as a strong competitor with solid profitability and growth metrics, while other peers exhibit varying degrees of financial health and valuation attractiveness.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
NURECA | ₹241.55 | ₹241.55Cr | -184.25 | -1.06% | 0.00 |
POLYMED | ₹2,072.30 | ₹20,997.79Cr | 63.37 | 20.37% | 0.06 |
LAXMIDENTL | ₹340.30 | ₹1,870.36Cr | 100.52 | 21.79% | 0.99 |
Prevest Denpro Ltd. | ₹569.55 | ₹683.63Cr | 37.56 | 25.24% | - |
Hemant Surgical Industries Ltd. | ₹297.80 | ₹310.90Cr | 38.24 | - | - |
Raaj Medisafe India Ltd. | ₹84.59 | ₹111.77Cr | 18.23 | - | - |
Kretto Syscon Ltd. | ₹1.69 | ₹106.00Cr | 18.53 | - | - |